January 2023 Newsletter
*1st Annual Latinx Conference on Problem Gambling (In-person) WHEN: January 13, 2023 8:00am-6:00pm CST
WHERE: Morton College Student Commons, Bldg. C 3801 S. Central Ave. Cicero, IL 60804Space is limited! RSVP today at 1st Annual Latinx Conference on Problem Gambling.
*Recovery Home Series– Part 5: Please join ICPG for the 5th Part of its Recovery Home Series. This webinar will describe the cycles of addictions, relapse risk factors, and different types of triggers that can contribute to relapse. WHEN: January 17, 2023 1:00pm-2:30pm CST. Register now by visiting Recovery Home Series– Part 5: Relapse Prevention Skills and Strategies.
*Alcohol Misuse & Mental Health in the Pandemic Era & Beyond -Alcohol consumption and related harms were increasing in the United States prior to the onset of the COVID-19 pandemic, particularly for women. The Alcohol Policy Resource Center is hosting the Alcohol Misuse and Mental Health in the Pandemic Era and Beyond webinar with Dr. Aaron White. 1.5 CEUs will be available for this live webinar. WHEN: January 19, 2023 10:00am-11:30am CST. To register for this webinar, please visit Alcohol Policy Resource Center (APRC).
SUPPORT Act Evaluation Survey Participation: Your participation is needed! The Centers for Medicare and Medicaid Services (CMS), the Substance Abuse and Mental Health Services Administration (SAMHSA), and the Agency for Healthcare Research and Quality (AHRQ) are evaluating the Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act section 1003 demonstration, enacted by Congress on October 24, 2018. The SUPPORT Act section 1003 aims to increase the capacity of Medicaid providers to deliver substance use disorder (SUD) treatment, including opioid use disorder (OUD) treatment and recovery services. We need your help with the SUPPORT Act section 1003 evaluation.
Your input is critical for assessing the impact of the SUPPORT Act on SUD and informing the future strategic direction of these efforts. IBM Consulting and NORC at the University of Chicago are conducting a survey of providers who prescribe buprenorphine and opioid treatment programs. If you have been selected to participate, you will receive an email or letter invitation in January 2023. Your response is important! You can view the survey questionnaire and learn more about the survey on NORC’s website here. If you have any questions about the survey, please contact the evaluation team at SUPPORT Act@norc.orgor 1-877-368-6572.